Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.12 USD | -0.64% | -3.10% | -2.80% |
14/05 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
14/05 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.80% | 22Cr | |
+8.38% | 12TCr | |
+13.04% | 11TCr | |
-13.56% | 2.23TCr | |
-3.99% | 2.16TCr | |
-5.62% | 1.82TCr | |
-39.93% | 1.76TCr | |
+7.51% | 1.43TCr | |
+33.73% | 1.24TCr | |
-28.32% | 828.11Cr |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target